ALAVERT ALLERGY

Product NDC
0573-2621
Requested package NDC
0573-2621-13
11-digit product format
005732621
Labeler code
0573
Product ID
0573-2621_1ad9e626-55ca-4d43-b5ec-cc4d5bf19b07
Type
HUMAN OTC DRUG
Nonproprietary name
loratadine
Dosage form
TABLET, ORALLY DISINTEGRATING
Route
ORAL
Labeler
GlaxoSmithKline Consumer Healthcare Holdings (US) LLC
Application
NDA021375
Marketing category
NDA
Marketing start
2002-12-19
Marketing end
0000-00-00
Substance
LORATADINE
Active strength
10 mg/1
NDC exclude flag
No
Listing certified through
2021-12-31
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded packagepackage0573-26210573-2621-13DDiscontinued by firm2026-11-16

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 16 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Code, Status table
Captured / source dateCodeStatusSnapshotSource SHA-256
2025-12-14 17:58 UTC · source 2025-12-05DDiscontinued by firmd630ba8d3edf…732f749b63fb…
2025-08-27 00:01 UTC · source 2025-08-26DDiscontinued by firmf5e01cc5f278…a2eaf40c39c3…
2025-04-01 02:39 UTC · source 2025-03-31DDiscontinued by firm2ef7874e63bc…57b86245f4fa…
2025-03-28 20:22 UTC · source 2025-03-28DDiscontinued by firma1b67e2a42f9…c4cf2c586c0d…
2025-03-22 03:12 UTC · source 2025-03-21DDiscontinued by firmcfe11265f3b6…090c488252e2…
2025-03-10 12:48 UTC · source 2025-03-10DDiscontinued by firmcdf11ea48f46…ba0047e9e063…
2025-02-02 03:52 UTC · source 2025-01-31DDiscontinued by firm302b2466d912…e7b80fea0513…
2025-01-20 13:05 UTC · source 2025-01-20DDiscontinued by firmed331223b511…672a5bd82f5f…
2025-01-11 03:41 UTC · source 2025-01-10DDiscontinued by firm0efc9e666f02…f202fb6c5f17…
2024-11-09 02:27 UTC · source 2024-11-08DDiscontinued by firmad56d346431e…cc804d4bbf1e…
2024-10-04 04:10 UTC · source 2024-10-03DDiscontinued by firm367a005e9d99…383a685ebd0f…
2024-07-10 04:00 UTC · source 2024-07-09DDiscontinued by firm557ba5c1ecfa…9c80585c8c6e…
2024-03-11 06:39 UTC · source 2024-03-08IInactivated by FDA1332a3947898…d4bfe170f9cd…
2022-08-30 03:57 UTC · source 2022-08-29IInactivated by FDAfb8cb913e6d1…eb8c232b6be0…
2022-04-09 23:13 UTC · source 2022-04-08IInactivated by FDA86f5da6cb304…a595104c45d7…
2022-04-04 05:40 UTC · source 2022-04-01IInactivated by FDAbd6a592717d7…303034d00443…

Source provenance: Browse the complete Orange Book source catalog · source snapshot 45.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N021375-001ALAVERTLORATADINE10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-19

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 45 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-11-14 07:37:172026-10N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-19d4dbc9d85df4…
2026-10-15 13:18:302026-09N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-19c2088c7a36db…
2026-09-14 22:38:342026-08N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-1984e616aacf4f…
2026-08-18 06:07:402026-07N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-19caaa826d4ba7…
2026-02-19 14:30 UTC2026-02N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-19011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-1931067a03dcf5…
2025-08-23 18:47 UTC2025-08N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-196a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-19fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-19b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-1903ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-192680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-195bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-19d8e5a09893c0…
2024-10-29 15:01 UTC2024-10N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-19d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-1979d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-19301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-191e350fbaab3a…
2024-05-31 18:47 UTC2024-05N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-198072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-195c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-195d02ea3f76ae…
2022-04-04 05:41 UTC2022-04N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-194b0b4de00fa7…
2019-12-13 00:20 UTC2019-12N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-1974a2ff9319b5…
2022-03-09 01:35 UTC2022-03N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-19bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-19782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-1987673890dc5c…
2021-03-12 10:30 UTC2021-03N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-195aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-198869cabd3fbd…
2020-11-12 02:37 UTC2020-11N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-19c0c555d07b60…
2019-12-14 00:12 UTC2019-12N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-193f01610625f2…
2019-09-15 20:21 UTC2019-09N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-19b00525d2431f…
2019-07-19 19:46 UTC2019-07N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-19ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-196a51e52b5d6a…
2024-02-18 07:12 UTC2024-02N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-191c564ffb4f44…
2023-12-20 04:57 UTC2023-12N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-19ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-19a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-199b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-19a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-193f0d92c62455…
2023-05-13 08:27 UTC2023-05N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-19053a50430f4f…
2023-01-26 05:58 UTC2023-01N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-193bdfa0b2c4d7…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Related label table
NDCEffectiveRelated label
0573-2621-132024-03-21Drug Facts
0573-2621-192024-03-21Drug Facts
0573-2621-652024-03-21Drug Facts
0573-2621-132022-01-28Drug Facts
0573-2621-192022-01-28Drug Facts
0573-2621-652022-01-28Drug Facts

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
0573-2621-19EA - Each0573-26211fcf8024-13e4-4f89-8a06-70c42d58133812014-01-04
0573-2621-65EA - Each0573-262188b60682-6817-47c6-87b5-205696e5dc0312012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
LORATADINEACTIVE INGREDIENT7AJO3BO7QNALAVERT ALLERGY (LORATADINE) TABLET, ORALLY DISINTEGRATING [PFIZER CONSUMER HEALTHCARE]7
LORATADINEACTIVE MOIETY7AJO3BO7QNALAVERT ALLERGY (LORATADINE) TABLET, ORALLY DISINTEGRATING [PFIZER CONSUMER HEALTHCARE]7
ANHYDROUS CITRIC ACIDINACTIVE INGREDIENTXF417D3PSLALAVERT ALLERGY (LORATADINE) TABLET, ORALLY DISINTEGRATING [PFIZER CONSUMER HEALTHCARE]7
ASPARTAMEINACTIVE INGREDIENTZ0H242BBR1ALAVERT ALLERGY (LORATADINE) TABLET, ORALLY DISINTEGRATING [PFIZER CONSUMER HEALTHCARE]7
BUTYLATED HYDROXYANISOLEINACTIVE INGREDIENTREK4960K2UALAVERT ALLERGY (LORATADINE) TABLET, ORALLY DISINTEGRATING [PFIZER CONSUMER HEALTHCARE]7
CELLULOSE, MICROCRYSTALLINEINACTIVE INGREDIENTOP1R32D61UALAVERT ALLERGY (LORATADINE) TABLET, ORALLY DISINTEGRATING [PFIZER CONSUMER HEALTHCARE]7
CORN SYRUPINACTIVE INGREDIENT9G5L16BK6NALAVERT ALLERGY (LORATADINE) TABLET, ORALLY DISINTEGRATING [PFIZER CONSUMER HEALTHCARE]7
CROSPOVIDONEINACTIVE INGREDIENT68401960MKALAVERT ALLERGY (LORATADINE) TABLET, ORALLY DISINTEGRATING [PFIZER CONSUMER HEALTHCARE]7
FERRIC OXIDE REDINACTIVE INGREDIENT1K09F3G675ALAVERT ALLERGY (LORATADINE) TABLET, ORALLY DISINTEGRATING [PFIZER CONSUMER HEALTHCARE]7
ICODEXTRININACTIVE INGREDIENT2NX48Z0A9GALAVERT ALLERGY (LORATADINE) TABLET, ORALLY DISINTEGRATING [PFIZER CONSUMER HEALTHCARE]7
MAGNESIUM STEARATEINACTIVE INGREDIENT70097M6I30ALAVERT ALLERGY (LORATADINE) TABLET, ORALLY DISINTEGRATING [PFIZER CONSUMER HEALTHCARE]7
MALTODEXTRININACTIVE INGREDIENT7CVR7L4A2DALAVERT ALLERGY (LORATADINE) TABLET, ORALLY DISINTEGRATING [PFIZER CONSUMER HEALTHCARE]7
MANNITOLINACTIVE INGREDIENT3OWL53L36AALAVERT ALLERGY (LORATADINE) TABLET, ORALLY DISINTEGRATING [PFIZER CONSUMER HEALTHCARE]7
SILICON DIOXIDEINACTIVE INGREDIENTETJ7Z6XBU4ALAVERT ALLERGY (LORATADINE) TABLET, ORALLY DISINTEGRATING [PFIZER CONSUMER HEALTHCARE]7
SODIUM BICARBONATEINACTIVE INGREDIENT8MDF5V39QOALAVERT ALLERGY (LORATADINE) TABLET, ORALLY DISINTEGRATING [PFIZER CONSUMER HEALTHCARE]7

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
0573-2621-130057326211312 BLISTER PACK in 1 CARTON (0573-2621-13) > 1 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK12 blister pack2016-12-190000-00-00NoNoCurrent